Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
505.80
-2.00
(-0.39%)
At close: February 24 at 5:24:25 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-20,418
-21,577
-23,678
-24,716
-19,514
Investing Cash Flow
278
-4,538
13,274
-20,566
9,415
Financing Cash Flow
4,069
18,152
9,343
30,276
20,374
End Cash Position
11,260
20,772
28,980
32,325
46,229
Capital Expenditure
-390
-785
-1,171
-847
-682
Issuance of Capital Stock
168
8,449
21
29,582
18,658
Issuance of Debt
--
--
10,000
--
--
Repayment of Debt
-907
-836
-803
-580
-639
Free Cash Flow
-20,808
-22,362
-24,849
-25,563
-20,196
12/31/2020 - 6/13/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PPBT.TA Purple Biotech Ltd
5.60
-1.75%
ARMP Armata Pharmaceuticals, Inc.
2.0800
-1.19%
DRTS Alpha Tau Medical Ltd.
2.7400
+2.24%
PPBT Purple Biotech Ltd
3.0600
-2.86%
GERN Geron Corporation
2.3900
-7.00%
SAVA Cassava Sciences, Inc.
2.5000
-1.96%
NVAX Novavax, Inc.
7.41
-7.26%
MRNA Moderna, Inc.
33.90
-4.59%